Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00036270
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2002-05-08
Brief Title:
Randomized Phase III Study Of Exemestane Aromasin For 5 Years Versus Tamoxifen for 25 to 3 Years Followed By Exemestane
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-08
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-08
First Submit QC Date:
May 8 2002
Study First Post Date:
2002-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-12-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-06
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED